Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

70.35 -0.13 (-0.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dexcom Inc

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Better Buy: DexCom or Abbott Labs?
Abbott's the heavyweight, and DexCom is the formidable challenger. 
Via The Motley Fool
5 Stocks Insiders Are Still Buying (Even As Others Cash Out)
Insider sales are generally a sign the market is about to drop, but not everyone's selling. Here are five companies with insider buying. 
Via InvestorPlace
Jim Cramer Shares His Thoughts On Innovative Industrial Properties, Nokia And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Poshmark, Inc. (NASDAQ: POSH) missed the quarter badly when others in that industry are doing quite well,... 
Via Benzinga
Expert Ratings For DexCom
Within the last quarter, DexCom (NASDAQ:DXCM) has observed the following an... 
Via Benzinga
Where DexCom Stands With Analysts
DexCom (NASDAQ:DXCM) has observed the following analyst ratings within the ... 
Via Benzinga
Analyst Ratings For DexCom
Analysts have provided the following ratings for DexCom (NASDAQ:DXCM) with... 
Via Benzinga
Expert Ratings For DexCom
Within the last quarter, DexCom (NASDAQ:DXCM) has observed the following an... 
Via Benzinga
Dexcom, Nick Jonas, Patti LaBelle and The Global Movement for Time in Range Invite the World to #SeeDiabetes This November
From Dexcom, Inc.
Via Business Wire
This Company Is Making Medical Testing and Care from Home the New Normal and You Don't Need Insurance
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Telehealth... 
Via Benzinga
10 Biggest Price Target Changes For Monday
Needham boosted the price target on ServiceNow, Inc. (NYSE: 
Via Benzinga
What 4 Analyst Ratings Have To Say About DexCom
Analysts have provided the following ratings for DexCom (NASDAQ:DXCM) with... 
Via Benzinga
Dexcom Q3 Earnings Beat Street, Raises FY21 Outlook Ahead Of G7 Launch
Dexcom Inc's (NASDAQ: DXCM) Q3 adjusted EPS of $0.89 though lower than $0.94 posted a year ago, came in sharply above the consensus of $0.63. Sales increased... 
Via Benzinga
Topics Earnings
Exposures Financial
10 Biggest Price Target Changes For Friday
Oppenheimer boosted the price target on Apple Inc. (NASDAQ:A... 
Via Benzinga
DexCom Inc (DXCM) Q3 2021 Earnings Call Transcript
DXCM earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: DexCom Q3 Earnings
DexCom (NASDAQ:DXCM) reported its Q3 earnings results on Thursday, October 28, 2021 at 04:02 PM. Here's what investors need to know about the announcement. Earnings DexCom... 
Via Benzinga
Dexcom Pops Closer To A Record High After Crushing Third-Quarter Forecasts
Dexcom easily topped Wall Street's third-quarter forecasts late Thursday. 
Via Investor's Business Daily
Dexcom Reports Third Quarter 2021 Financial Results
From DexCom, Inc.
Via Business Wire
2 Unstoppable Stocks to Buy and Hold for Decades
These are investments that you won't need to worry about. 
Via The Motley Fool
Dexcom Schedules Third Quarter 2021 Earnings Release and Conference Call for October 28, 2021 at 4:30 p.m. Eastern Time
From Dexcom, Inc.
Via Business Wire
1 Supercharged Healthcare Stock to Buy Right Now
The stock isn't a household name, but it's generated multibagger returns over the past five years alone. 
Via The Motley Fool
Ignore GameStop: Here Are 2 Better Stocks
The performance of these two companies isn't detached from their financial results. 
Via The Motley Fool
Exposures COVID-19
Dexcom Insider Sold Over $3.87 Million In Company Stock
Steven R Pacelli, Managing Dir. And Dexcom Ventures at Dexcom (NASDAQ:DXCM), made a large insider sell on September 23, according to a new SEC filing. What Happened: A Form 4... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Desperate for Solutions, Diabetes and Obesity Healthcare Sectors Find Answers, Hope in Innovative Tech
Via Investor Brand Network
Exposures COVID-19
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (... 
Via Benzinga
Exposures COVID-19
Dexcom Insider Sold Over $3.24 Million In Company Stock
Kevin R Sayer, CEO And President at Dexcom (NASDAQ:DXCM), made a large insider sell on September 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S.... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Notable Dexcom Insider Makes $3.06 Million Sale
Andrew K Balo, * at Dexcom (NASDAQ:DXCM), made a large insider sell on September 9, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (... 
Via Benzinga
Non-insured Health Benefits Program Now Covers Dexcom G6 Continuous Glucose Monitoring System for Children and Adolescents on Intensive Insulin Therapy
From Dexcom, Inc.
Via Business Wire
Notable Dexcom Insider Makes $10.22 Million Sale
Quentin S Blackford, Chief Operating Officer at Dexcom (NASDAQ:DXCM), made a large insider sell on September 10, according to a new SEC filing. What Happened: A Form 4 filing... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.